Asset Allocation

As of September 30, 2025.
Type % Net
Cash 4.77%
Stock 45.02%
Bond 46.88%
Convertible 0.00%
Preferred 0.23%
Other 3.10%
View Asset Allocation
Start Trial

Market Capitalization

As of September 30, 2025
Large 81.69%
Mid 14.07%
Small 4.24%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 88.39%    % Emerging Markets: 2.74%    % Unidentified Markets: 8.87%

Americas 75.09%
73.30%
Canada 49.64%
United States 23.66%
1.79%
Chile 0.60%
Mexico 1.19%
As of September 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 10.89%
United Kingdom 1.54%
9.36%
France 2.17%
Germany 2.11%
Italy 1.16%
Netherlands 2.22%
Switzerland 1.70%
0.00%
0.00%
Greater Asia 5.14%
Japan 4.19%
0.00%
0.00%
0.95%
India 0.95%
Unidentified Region 8.87%

Bond Credit Quality Exposure

AAA 29.79%
AA 3.82%
A 18.06%
BBB 18.60%
BB 1.41%
B 5.98%
Below B 3.49%
    CCC 3.26%
    CC 0.23%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.93%
Not Available 17.92%
Short Term 0.00%
As of September 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
15.81%
Materials
0.00%
Consumer Discretionary
2.61%
Financials
11.24%
Real Estate
1.96%
Sensitive
11.45%
Communication Services
3.23%
Energy
0.00%
Industrials
5.91%
Information Technology
2.31%
Defensive
18.22%
Consumer Staples
10.39%
Health Care
5.12%
Utilities
2.71%
Not Classified
54.53%
Non Classified Equity
1.33%
Not Classified - Non Equity
53.20%
As of September 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of September 30, 2025
Type % Net
Government 29.40%
Corporate 55.59%
Securitized 0.33%
Municipal 0.00%
Other 14.68%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.50%
Less than 1 Year
4.50%
Intermediate
83.63%
1 to 3 Years
23.29%
3 to 5 Years
28.26%
5 to 10 Years
32.08%
Long Term
11.86%
10 to 20 Years
0.17%
20 to 30 Years
0.89%
Over 30 Years
10.79%
Other
0.00%
As of September 30, 2025
View Bond Maturity Exposure
Start Trial